Andrew Hessel, Genomic Futurist

Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes ahead in life science. He is a Distinguished Researcher with Autodesk Inc.’s Bio/Nano Programmable Matter group, based out of San Francisco. He is also the co-founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.

Trained in microbiology and genetics, Andrew has continually worked at the forefront of genomics, first to read and comprehend bacterial, human, and other genomes and more recently to write them. He believes the technology that makes this possible, called synthetic biology, is revolutionary and that it will eventually surpass information technology (IT) as an economic engine and driver of societal change. He speaks widely on topics that include cells as living computers, life science as an emerging IT industry, and biological safety and security.

Donate BTC: 1DUUZbiqjbJvzjuRZEwTS47bqgmnhEJ4XG

Donate ETH: 0x981FcEAAa895C6cee76D2876e9AfC649Dc0C4c75

More Posts:

The Future Of Shopping
Back To The Roots: To Know The Food Origin
Prototype Design Printing In 3D
Blind Cave Fish Inspired Sensors Enable Efficient Navigation Of The AUVs
Michio Kaku: This is Your Brain on a Laser Beam
Desktop-Sized Laser Supercomputers Could Be Coming By 2020
A Giant Pac-Man To Gobble Up Space Debris
Eternal 5D Optical Data Storage: High Density Data Storage For All-Time
UC Berkeley Have Built 'Neural Dust' Wireless Sensors For Body
Jumping Water Droplets Could Be the Future of Cooling Computers